Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-23-183831
Filing Date
2023-07-07
Accepted
2023-07-07 16:33:26
Documents
3
Group Members
SHENANDOAH ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D d266530dsc13d.htm SC 13D 88423
2 EX-2.2 d266530dex22.htm EX-2.2 66749
3 EX-99.1 d266530dex991.htm EX-99.1 3963
  Complete submission text file 0001193125-23-183831.txt   160863
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Subject) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92195 | Film No.: 231077172
SIC: 2834 Pharmaceutical Preparations